Metrics as of 10/13/2026, 06:32 PM (Berlin time), refresh in progress.
Eckert & Ziegler SE
Eckert & Ziegler SE is a healthcare company specializing in medical specialties. Founded in 1992 and headquartered in Berlin, Germany, the company has been listed on XETRA since its IPO on May 26, 1999. The firm employs approximately 1,105 employees. It operates through two primary segments, Medical and Isotope…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
1D
+0.2%
1W
+2.9%
1M
+0.6%
6M
-21.2%
YTD
-18.9%
1Y
-28.1%
2Y
-11.5%
5Y
-66.0%
10Y
+587.2%
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~35% weaker price swings than usual
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
P/E
15.46
P/B
2.89
EV/EBITDA
7.56
RETURN ON EQUITY
4.5%
NET MARGIN
15.7%
DEBT/EQUITY
0.15
DIVIDEND YIELD
1.8%
AS OF
30/06/2026
FREE FLOAT
64.3%
FLOAT SHARES
40,263,302
AVG. DAILY VOLUME (30D)
96,390
Eckert & Ziegler SE is a company in the Healthcare sector, Medical - Specialties industry, headquartered in Germany.
The CEO is Harald Hasselmann, the company employs around 1,105 people.
The IPO was on 26/05/1999; the stock trades on XETRA under the ticker EUZ.DE.
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly -35% stronger than usual.
Yes. The last dividend was €0.22 per share, ex-date 25/06/2026, paid on 29/06/2026.
The dividend yield is 1.8% (as of 30/06/2026).
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Merck, Siemens Healthineers and Bayer Aktiengesellschaft.
Clicking "Analyze stock" lets five strategies assess Eckert & Ziegler against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.